{"name": "ELARA Pharmaceuticals",
 "permalink": "elara-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/elara-pharmaceuticals",
 "homepage_url": "http://www.elarapharma.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2006,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "+49 6221 387 8935",
 "description": "Biopharmaceutical company",
 "created_at": "Mon Nov 30 21:31:04 UTC 2009",
 "updated_at": "Fri Jan 29 15:17:05 UTC 2010",
 "overview": "\u003Cp\u003EElara Pharmaceuticals Gmbh provides research and pharmaceutical development services for new anti-cancer drugs. In addition Elara Pharmaceuticals Gmbh has discovered lead series of small, bioactive molecules that have anti-tumour activity, based on inhibitors of estrogen signaling and Aurora kinases. Elara Pharmaceuticals Gmbh was founded in 2006 and is based in Heidelberg, Germany.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       58],
      "assets/images/resized/0006/8029/68029v1-max-150x150.png"],
     [[250,
       97],
      "assets/images/resized/0006/8029/68029v1-max-250x250.png"],
     [[304,
       119],
      "assets/images/resized/0006/8029/68029v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$6.91M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.elarapharma.com/pdf/press_e_20091125.pdf",
    "source_description": "ELARA Pharmaceuticals",
    "raised_amount": 6910000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 11,
    "funded_day": 26,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "EMBL Ventures",
         "permalink": "embl-ventures",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0006/8288/68288v1-max-150x150.jpg"],
             [[191,
               67],
              "assets/images/resized/0006/8288/68288v1-max-250x250.jpg"],
             [[191,
               67],
              "assets/images/resized/0006/8288/68288v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "KFW",
         "permalink": "kfw-2",
         "image":
          {"available_sizes":
            [[[150,
               87],
              "assets/images/resized/0006/8115/68115v1-max-150x150.png"],
             [[180,
               105],
              "assets/images/resized/0006/8115/68115v1-max-250x250.png"],
             [[180,
               105],
              "assets/images/resized/0006/8115/68115v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "WFT",
         "permalink": "wft",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "",
    "address2": "",
    "zip_code": "",
    "city": "Boxbergrin",
    "state_code": null,
    "country_code": "DEU",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}